Abstract
The emergence of proteomic techniques and methodological approaches to study disease has kindled the quest for new biomarkers. Thus, the use of protein microarrays has surged as a powerful tool for large-scale testing of biological samples. In this mini-review, we will discuss the application of protein microarray technologies that offer unique opportunities to find novel biomarkers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Frank R, Hargreaves R (2003) Clinical biomarkers in drug discovery and development. Nat Rev Drug Discov 2:566–580
Rifai N, Gillete MA, Carr SA (2006) Protein biomarkers discovery and validations: the long and uncertain path to clinical utility. Nat Biotechnol 24:971–983
Sokoll LJ, Chan DW (1997) Prostate-specific antigen. Its discovery and biochemical characteristics. Urol Clin North Am 24:253–259
Rustin GJ, Bast RC Jr, Kelloff GJ et al (2004) Use of CA-125 in clinical trial evaluation of new therapuetic drugs for ovarian cancer. Clin Cancer Res 10:3919–3926
Baker M (2005) In biomarkers we trust? Nat Biotechnol 23:297–304
Wingren C, Borrebaeck C (2006) Antibody microarrays: current status and key technological advances. OMICS 10:411–417
Haab B, Dunham M, Brown P (2001) Protein microarrays for highly parallel detection and quantification of specific proteins and antibodies in complex solutions. Genome Biol 2:157
Anderson KS, Labaer J (2005) The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res 4:1123–1133
Wingren C, Ingvarsson J, Lindstedt M et al (2003) Recombinant antibody microarrays: a viable option? Nat Biotechnol 21:223
Söderlind E, Standberg L, Jirholt P, et al (2000) Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat Biotechnol 18:852–856
Borrebaeck CA, Ohlin M (2002) Antibody evolution beyond Nature. Nat Biotechnol 20:1189–1190
Ingvarsson J, Larson A, Sjöholm AG et al (2007) Design of recombinant antibody microarrays for serum protein profiling: targeting of complement proteins. J Proteome Res 6:3527–3536
Kusnezow W, Banzon V, Schröder C et al (2007) Antibody microarray-based profiling of complex specimens: systematic evaluation of labeling strategies. Proteomics 7:1786–1799
Wingren C, Ingvarsson J, Dexliln L et al (2007) Design of recombinant antibodies microarrays for complex proteome analysis: choice of sample labeling-tag and solid support. Proteomics 7:3055–3065
Miller JC, Zhouw H, Kwekel J, et al (2003) Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers. Proteomics 3:56–63
Sanchez-Carbayo M, Socchi ND, Lozano JJ et al (2006) Profiling bladder cancer using targeted antibody arrays. Am J Pathol 168:93–103
Ellmark P, Ingvarsson J, Carlsson A et al (2006) Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol Cell Proteomics 5:1638–1646
Charboneau L, Toary H, Cehn T et al (2002) Utility of reverse phase protein arrays: applications to signaling pathways and human body arrays. Brief Funct Genomics Proteomics 1:305–315
Paweletz CP, Charboneau L, Bischel VE et al (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20:1981–1999
Speer R, Wulfkuhle JD, Liotta LA, Petricoin EF 3rd (2005) Reverse phase protein microarrays for tissue-based analysis. Curr Opin Mol Ther 7:240–245
Nishizuka S, Charboneau L, Yound L et al (1998) Proteomic profiling of NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci U S A 95:6919–6923
Wu W, Slåstad H, de la Rosa Carrillo D et al (2009) Antibody array analysis with label-based detection and resolution of protein size. Mol Cell Proteomics 8:245–257
Schwenk JM, Igel U, Neiman M et al (2010) Toward next generation plasma profiling via heat-induces epitope retrieval and array-based assays. Mol Cell Proteomics 9:2497–2507
Anderson KS, Ramachandran N, Wong J et al (2008) Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J Proteome Res 7:1490–1499
Murthy TV, Wu W, Qiu QQ et al (2004) Bacterial cell-free system for high-throughput protein expression and a comparative analysis of Escherichia coli cell-free and whole cell expression systems. Protein Expr Purif 36:217–225
Rolfs A, Hu Y, Ebert LD et al (2008) A biomedically enriched collection of 7000 human ORF clones. PLoS One 3:e1528
He M, Taussig MJ (2001) Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method). Nucleic Acids Res 29:E73–73
Ramachandran N, Raphael JV, Hainsworth E et al (2008) Next-generation high-density self-assembling functional protein arrays. Nat Methods 5:535–538
Ramachandran N, Hainsworth E, Bhullar B et al (2004) Self-assembling protein microarrays. Science 305:86–90
Tao S-C, Zhu H (2006) Protein chip fabrication by capture of nascent polypeptides. Nat Biotechnol 24:1253–1254
Anderson KS, Sibani S, Wallstrom G et al (2011) Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. J Proteome Res 10:85–96
Ramirez AB, Loch CM, Zhang Y et al (2010) Use of a single-chain antibody library for ovarian cancer biomarker discovery. Mol Cell Proteomics 9:1449–1460
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matarraz, S., González-González, M., Jara, M. et al. New technologies in cancer. Protein microarrays for biomarker discovery. Clin Transl Oncol 13, 156–161 (2011). https://doi.org/10.1007/s12094-011-0635-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-011-0635-8